Compare DexCom, Inc. (DXCM) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs United States Natural Gas Fund — how do they compare? DexCom, Inc. trades at $90.58 (market cap $34.26B), while United States Natural Gas Fund trades at $9.98. The key difference: DexCom, Inc. is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| DXCM | UNG | |
|---|---|---|
Market Cap | $34.26B | — |
Sector | Health | Commodities - Energy |
52-Week High | $90.80 | $16.90 |
52-Week Low | $54.84 | $9.63 |
Enterprise Value | $33.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
UNG trades at $10.20, up 0.59% with a bearish technical signal from moving averages. The ETF shows neutral momentum oscillators with mixed directional indicators. Recent news highlights natural gas price stability amid weather-driven demand fluctuations and ongoing discussions about futures versus equity exposure in the natural gas sector.
The outlook remains cautious with technical weakness offset by fundamental supply-demand dynamics. Investment opportunities exist in potential weather-driven price spikes, while risks include commodity volatility and the structural challenges of futures-based ETFs tracking spot prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
